Business Context and Reporting Period
This Form 8-K reports on the 2022 Annual Meeting of Stockholders held by LeMaitre Vascular, Inc. on June 1, 2022. The filing details the voting results for three proposals submitted to security holders.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting outcomes.
Material Changes and Voting Results
Stockholders voted on three matters at the Annual Meeting. A total of 20,283,689.6 shares were present in person or by proxy out of 21,951,938 shares entitled to vote.
- Proposal 1 (Election of Directors): Stockholders elected George W. LeMaitre and David B. Roberts as Class I directors for three-year terms.
- George W. LeMaitre: 16,025,727.6 shares for, 3,224,663 shares withheld.
- David B. Roberts: 17,820,028.6 shares for, 1,430,362 shares withheld.
- Proposal 2 (Advisory Vote on Executive Compensation): Approved by 18,995,635.6 shares for, 223,867 shares against, and 30,888 shares abstaining.
- Proposal 3 (Ratification of Auditors): Stockholders ratified the appointment of Grant Thornton LLP as the independent registered public accounting firm for 2022. The vote was 20,271,264.6 shares for, 2,242 shares against, and 10,183 shares abstaining.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Important Facts for Investors to Verify
- Confirmation that Grant Thornton LLP is the appointed auditor for the fiscal year ending December 31, 2022.
- The specific terms and expiration dates for the newly elected Class I directors (expiring at the 2025 Annual Meeting).
- The level of shareholder support for executive compensation, noting the relatively low number of votes against the advisory proposal.